Main Catalog

AMCP Web Site

Main Catalog

Found 92

Sort by

Member $349.00

Non-Member $449.00

Value-Based Contracting E-Learning Program

Not accredited for CPE: An interactive self-paced e-Learning training program designed to fit into your busy schedule and deliver the basics with seven 40-minute modules.

Value-Based Contracting

Member Free

Non-Member Free

C Diff JMCP Supplement

JMCP Contact Hours: 1.5 - Clostridioides difficile (C. diff, previously known as Clostridium difficile) infections are a major health care concern.

C. Diff

Member Free

Non-Member Free

Heart Failure: Advances in Medications and Technology Home Study

Contact Hours: 1. 0 - Heart failure (HF) is one of the costliest diseases in the United States.

Heart Failure

Member Free

Non-Member Free

PrEPing for Change: The Impact of PrEP Guideline Updates for Preventing HIV Infections

Contact Hours: 1 - Effective prevention strategies for HIV infection are an important public health priority.

HIV

Member $199.00

Non-Member $249.00

Fundamentals of Managed Care Pharmacy Certificate Program 2nd Edition | Student Version

Not Accredited for CPE: The Fundamentals of Managed Care Pharmacy Certificate Program provides a comprehensive introduction to basic concepts in managed care pharmacy.

Fundamentals of Managed Care Pharmacy

Member $399.00

Non-Member $499.00

Fundamentals of Managed Care Pharmacy Certificate Program 2nd Edition - Professional Version

Contact Hours: 8.75 - The Fundamentals of Managed Care Pharmacy Certificate Program provides a comprehensive introduction to basic concepts in managed care pharmacy.

Fundamentals of Managed Care Pharmacy

Member $15.00

Non-Member $30.00

Federal and State Legislative and Regulatory Update Home Study Nexus 2020

Contact Hours: 1 - In today’s world there are many uncertainties, especially with the COVID-19 pandemic, but health care legislation and regulation continue to move at a staggering pace.

AMCP Nexus 2020 Law

Member $15.00

Non-Member $30.00

Developments, Research, Pipeline, and Applications of Gene Therapy - Annual 2019

Contact Hours: 0.75: Gene therapy is a promising treatment option for a number of diseases, including inherited disorders, some types of cancer, and certain viral infections. The first gene therapy approvals in the United States occurred in 2017.

Gene Therapy

Member $15.00

Non-Member $30.00

Perspectives in Gene Therapy Management - Annual Meeting 2019

Contact Hours: 1 - The potential for gene therapy to transform the treatment of a wide variety of health conditions has important implications for many stakeholders.

Gene Therapy

Member $15.00

Non-Member $30.00

Introduction to Gene Therapy: Key Terms, Concepts, and International Perspectives - Annual Meeting 2019

Contact Hours: 1 - Gene therapy is an investigational technique that offers exciting promise of curing many debilitating and potentially terminal diseases, such as cystic fibrosis, multiple sclerosis, hemophilia, sickle cell disease, and spinal muscular atrophy.

Gene Therapy

Member $15.00

Non-Member $30.00

The Present and Future of Hemophilia Treatment - Annual Meeting 2018

Contact Hours: 1 - Over the past few decades, the treatment of hemophilia has been transformed by the emergence of safer clotting factor replacement products, and the growing use of prophylactic therapy to prevent bleeding and joint destruction.

Hemophilia

Member $15.00

Non-Member $30.00

Perspectives in Hemophilia Management - Annual Meeting 2018

Contact Hours: 1 - The treatment of hemophilia has evolved from a one-size-fits-all approach to a highly individualized care approach, and it continues to become more
patient-centered and specific.

Hemophilia

Member $15.00

Non-Member $30.00

Managing Patients with Hemophilia: A Payer’s Perspective - Annual Meeting 2018

Contact Hours: 1 - Thanks to significant improvements in the treatment of hemophilia, patients are living longer than ever before, with higher expectations for
near-normal quality of life.

Hemophilia

Member $15.00

Non-Member $30.00

Gene Therapy for Hemophilia: Hope for a Cure? - Annual Meeting 2018

Contact Hours: 0.75. The best currently available treatments for hemophilia reduce but do not eliminate the possibility of bleeding.

Hemophilia

Member Free

Non-Member $30.00

Placing Potential Cures Within Reach: Real-World Experience and Evolving Management Home Study

Contact Hours: 1 - A prominent health care payer and pharmacy benefit manager (PBM) will share their real-world experiences and learnings in managing innovative and expensive gene therapies.

AMCP eLearning Days Potential Cures

Member Free

Non-Member $30.00

Oncology: Investigating Trends and Elucidating Value - Home Study

Contact Hours: 1 - Cancer is one of the world’s most pressing health care challenges, with more than 14 million people receiving a cancer diagnosis each year.

Oncology AMCP eLearning Days

Member Free

Non-Member $30.00

Health Policy Trends Impacting Managed Care Pharmacy: Are You Ready?

Not Accredited for CPE: Congress, the White House, and presidential candidates are proposing major health policy changes in an election year where health care is a top issue on voters’ minds.

Health Policy AMCP eLearning Days

Member Free

Non-Member $30.00

Getting Up to Speed on Prescription Drug Pricing Reform Efforts Home Study

Contact Hours: 1 - Prescription drug pricing reform is a high-profile issue heading into the 2020 elections. President Trump, members of Congress, and the Democratic presidential candidates.

AMCP eLearning Days Drug Pricing

Member Free

Non-Member $30.00

Drug Pipeline: Traditional Pharmaceuticals and Biosimilars Home Study

Contact Hours: 1 - This session focuses on new and emerging traditional pharmaceutical brand-name drugs, as well as upcoming generic and biosimilar drug approvals.

Drug Pipeline AMCP eLearning Days

Member Free

Non-Member $30.00

Evaluating Digital Therapeutics, Drugs, and Health Technology for Optimizing Clinical and Financial Outcomes Home Study

Contact Hours: 1 - Utilization management practices are applied to medications in many therapeutic areas, but present unique challenges with digital therapeutics (DTx) and digital health tools.

Digital Health AMCP eLearning Days

Member Free

Non-Member $30.00

Digital Therapeutics: Understanding the Emerging Product Class Home Study

Contact Hours: 1 - Digital therapeutics (DTx) are emerging as a novel treatment modality for a wide range of health conditions, either as stand-alone products or for use in conjunction with other treatments.

Digital Health AMCP eLearning Days

Member Free

Non-Member $30.00

Developing Professional Strategies to Enhance Digital Engagement

Not Accredited for CPE: 2020 will no doubt be the year of digital engagement. On this webinar, Digital Marketing Strategist Eddie Bradley will share tips and insights on how subject matter experts and industry leading brands are leveraging content to grow and further engage with their audience.

Digital Engagement AMCP eLearning Days

Member Free

Non-Member $30.00

Cannabis Use in Health Care: What Payers Need to Know Home Study

Contact Hours: 1 - Despite a lack of regulatory and legal clarity, significant numbers of patients in Medicare, Medicaid, CHIP, and commercial plans currently use medical cannabis.

AMCP eLearning Days Cannabis

Member Free

Non-Member $30.00

2019-2020 Pharmaceutical Marketplace Trends

Not Accredited for CPE: This online program will provide an up-to-the-minute analysis of the pharmaceutical market and offer predictions about what lies ahead in the coming months as the health care industry manages the COVID-19 pandemic.

AMCP eLearning Days 2019-2020 Trends

Member Free

Non-Member Free

Perspectives on Providing Value in Oncology: A Panel Discussion

Contact Hours: 1 - Perceptions of value in oncology care vary among stakeholders.

Oncology Specialty Connect 2020

Member Free

Non-Member Free

Legal and Regulatory Considerations Impacting Oncology Specialty Pharmacy

Contact Hours: 1 - Laws and regulations at the state and federal level that impact oncology care.

Oncology Specialty Connect 2020

Member Free

Non-Member Free

Innovations in Managed Care for Oncology Specialty Pharmacy

Contact Hours: 1 - Benefit designs and management tools promoting high-quality care while simultaneously addressing total cost of care.

Oncology Specialty Connect 2020

Member Free

Non-Member Free

Evolving Oncology Treatment Options— Recent Approvals and a Look to the Future

Contact Hours: 1 - Over 1,100 biopharmaceutical products are currently in the oncology pipeline andnumerous new treatments approved by the FDA each year.

Oncology Specialty Connect 2020

Member $15.00

Non-Member $30.00

Keeping Up with Rare Disease Therapies: Pipeline to Management Solutions Track

Contact Hours: 1 - Over the last several years, payers have increased their focus on the management of rare diseases.

Rare Diseases

Member $15.00

Non-Member $30.00

White and Brown Bagging: Emerging Practice, Legislative and Board of Pharmacy Trends

Contact Hours: 1 - The growth of specialty pharmacy has resulted in an increase of white bagging and brown bagging.

Brown Bagging

Member $15.00

Non-Member $30.00

Value-Based Payment Models: Opportunities to Integrate Pharmacists from a Variety of Practice Settings

Contact Hours: 1 - Shared savings plans can mitigate health care costs, but how do we establish the relationships required for their success?

Value-Based Payment

Member $15.00

Non-Member $30.00

The State of Prescription Drug Pricing Reform: Are States Leading the Way for the US?

Contact Hours: 1 - Debates from Washington, D.C. frequently drown out changes happening in state capitals. This is true for drug pricing as well.

Drug Pricing

Member $15.00

Non-Member $30.00

The Role of Health Disparities and Social Determinants of Health in Promoting Health and Health Equity

Contact Hours: 1 - Health care disparities are often viewed through the lens of race/ethnicity and socioeconomic status.

Health Disparities

Member $15.00

Non-Member $30.00

The Evolving Role of Managed Care in the Gene Therapy Era: Focus on Hemophilia

Contact Hours: 1 - The first gene therapies for hemophilia A and B are expected to reach the market by 2022, with more projected in the coming years.

Gene Therapy

Member $15.00

Non-Member $30.00

Specialty Pharmaceuticals in Development Nexus 2020

Contact Hours: 1 - Over the last several years, approvals of specialty pharmaceuticals have far outpaced those of traditional drugs.

Specialty

Member $15.00

Non-Member $30.00

Population Management: Zooming in on Rare Diseases with ICER Reports

Contact Hours: 1 - An estimated 10% of the population has a rare disease, according to the National Organization of Rare Disorders (NORD), which lists over 1,200 rare diseases.

ICER

Member $15.00

Non-Member $30.00

Overcoming Barriers to Biosimilar Adoption through Coordinated Efforts

Contact Hours: 1 - Biosimilars are considered a fundamental pillar to containing drug spend in today’s health care systems.

Biosimilars

Member $15.00

Non-Member $30.00

Managing Different Perspectives: Panel Discussion on Integrating Medical and Pharmacy Benefits

Contact Hours: 1 - With several new treatments crossing the traditional dividing lines between medical and pharmacy benefits, there are many questions on how to best manage the coverage for these medications.

Hospital/Health Systems

Member $15.00

Non-Member $30.00

Keeping Up with State Legislators: Legislative Updates and Outlook

Contact Hours: 1 - The COVID-19 pandemic had a significant impact on state legislation and regulation.

Law

Member $15.00

Non-Member $30.00

Impact of Prescription Drug Reference Pricing on Drug Spend and Utilization

Contact Hours: 1 - Prescription drug reference pricing is an emerging pharmacy benefit management tool that aligns plan reimbursement to clinical value.

Drug Pricing

Member $15.00

Non-Member $30.00

How is Real-World Evidence in Oncology Used by Payers in Decision-Making? Home Study

Contact Hours: 1 - Payers face significant and growing costs with oncology treatments.

Oncology

Member Free

Non-Member $30.00

How Continued Drug Shortages Compromise Patient Care

Contact Hours: 1.5. Providing safe and effective drug therapy has become extremely challenging during extended periods of drug shortages.

Drug Shortages

Member Free

Non-Member $30.00

Preventative Treatment for Alzheimer’s Disease and the Future Role of Value-Based Payment Arrangements

Contact Hours: 1.5. The current understanding of Alzheimer’s disease is evolving.

Alzheimer's

Member Free

Non-Member $30.00

The Managed Care Evaluation of Non-Alcoholic Steatohepatitis Treatment Options

Contact Hours: 1.5. Non-alcoholic steatohepatitis (NASH) is a liver disease resulting from metabolic dysfunction that can lead to serious and costly health conditions, such as inflammation, hepatocellular injury, progressive fibrosis, and cirrhosis.

NASH

Member Free

Non-Member $30.00

Increasing Positive Outcomes: The Impact of Social Determinants of Health

Contact Hours: 1.5. There is a growing body of evidence that highlights how social determinants of health—socioeconomic status, education, physical environment, employment, and social support networks—play a large role in determining overall health outcomes.

Social Determinants

Member Free

Non-Member $30.00

Real-Time Pharmacy Benefits: Results and Learnings from a Real-World Implementation

Contact Hours: 1.5. Real-time pharmacy benefits (RTPB) deliver real-time access to medication pricing and restriction information at the point of prescribing.

Real-TIme Pharmacy

Member Free

Non-Member $30.00

Checking In on Health Care Reform Efforts: What Do They Mean for Payers, Manufacturers, and Patients?

Contact Hours: 1.5. While broader drug pricing reform efforts have taken the lion’s share of attention in health policy discourse over the past year, the Trump Administration has continued to move forward with implementing changes to the Affordable Care Act (ACA).

Health Care Reform

Member Free

Non-Member $30.00

Innovative Value-Based Contracting Approaches with Comprehensive Clinical Strategies

Contact Hours: 1.5. Innovative approaches to developing value-based contracts in the market need to be multi-faceted.

Value-Based Contracting

Member Free

Non-Member $30.00

Fast and Furious: What is Driving the Specialty Spend?

Contact Hours: 1.5. In 2018, the United States spent an estimated $517 million on specialty drugs. While specialty medications make up only about 1–2 % of all prescriptions written, they account for nearly 50% of total drug spend.

Specialty Drug Spend

Member Free

Non-Member $30.00

The Times They Are a-Changin – A Look at Congressional Efforts to Reform the Medicare and Medicaid Prescription Drug Programs

Contact Hours: 1.5. For more than a decade, millions of American seniors have been able to access prescription drugs through market-driven programs.

Prescription Drug Program

Main Catalog

Error